Literature DB >> 21918527

Cardiac remodeling and diastolic dysfunction in DahlS.Z-Lepr(fa)/Lepr(fa) rats: a new animal model of metabolic syndrome.

Tamayo Murase1, Takuya Hattori, Masafumi Ohtake, Mayuna Abe, Yui Amakusa, Miwa Takatsu, Toyoaki Murohara, Kohzo Nagata.   

Abstract

We recently characterized male DahlS.Z-Lepr(fa)/Lepr(fa) (Dahl salt-sensitive (DS)/obese) rats, which were established from a cross between Dahl salt-sensitive and Zucker rats, as a new animal model of metabolic syndrome (MetS). We have now investigated cardiac pathophysiology and metabolic changes in female DS/obese rats in comparison with homozygous lean female littermates (DahlS.Z-Lepr(+)/Lepr(+), or DS/lean, rats). Animals were maintained on a normal diet and were subjected to echocardiography followed by various pathological analyses at 15 weeks of age. Systolic blood pressure was significantly higher in female DS/obese rats than in DS/lean females at 12 weeks of age and thereafter. The survival rate of DS/obese rats was significantly lower than that of DS/lean rats at 15 weeks. Body weight, as well as visceral and subcutaneous fat mass were significantly increased in DS/obese rats, which also manifested left ventricular (LV) diastolic dysfunction and marked LV hypertrophy and fibrosis. In addition, myocardial oxidative stress and inflammation were increased in DS/obese rats compared with DS/lean rats. Serum insulin and triglyceride levels as well as the ratio of low-density lipoprotein- to high-density lipoprotein-cholesterol levels were markedly elevated in DS/obese rats, whereas fasting serum glucose concentrations were similar in the two rat strains. The phenotype of female DS/obese rats is similar to that of MetS in humans. These animals also develop salt-sensitive hypertension and LV diastolic dysfunction as well as LV hypertrophy and fibrosis, and these changes are associated with increased cardiac oxidative stress and inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21918527     DOI: 10.1038/hr.2011.157

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  31 in total

1.  Regularly consuming a green/roasted coffee blend reduces the risk of metabolic syndrome.

Authors:  Beatriz Sarriá; Sara Martínez-López; José Luis Sierra-Cinos; Luis García-Diz; Raquel Mateos; Laura Bravo-Clemente
Journal:  Eur J Nutr       Date:  2016-10-13       Impact factor: 5.614

Review 2.  Understanding diabetes-induced cardiomyopathy from the perspective of renin angiotensin aldosterone system.

Authors:  Vijayakumar Sukumaran; Narasimman Gurusamy; Huseyin C Yalcin; Sundararajan Venkatesh
Journal:  Pflugers Arch       Date:  2021-12-30       Impact factor: 3.657

3.  Blockade of glucocorticoid receptors with RU486 attenuates cardiac damage and adipose tissue inflammation in a rat model of metabolic syndrome.

Authors:  Yuuri Takeshita; Shogo Watanabe; Takuya Hattori; Kai Nagasawa; Natsumi Matsuura; Keiji Takahashi; Toyoaki Murohara; Kohzo Nagata
Journal:  Hypertens Res       Date:  2015-07-09       Impact factor: 3.872

Review 4.  Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.

Authors:  Ian J Neeland; Paul Poirier; Jean-Pierre Després
Journal:  Circulation       Date:  2018-03-27       Impact factor: 29.690

5.  Comparative effects of valsartan in combination with cilnidipine or amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats.

Authors:  Kai Nagasawa; Keiji Takahashi; Natsumi Matsuura; Miwa Takatsu; Takuya Hattori; Shogo Watanabe; Eri Harada; Kazumi Niinuma; Toyoaki Murohara; Kohzo Nagata
Journal:  Hypertens Res       Date:  2014-09-11       Impact factor: 3.872

Review 6.  Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities.

Authors:  Michele Cavalera; Junhong Wang; Nikolaos G Frangogiannis
Journal:  Transl Res       Date:  2014-05-10       Impact factor: 7.012

Review 7.  Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Authors:  Tiffany M Powell-Wiley; Paul Poirier; Lora E Burke; Jean-Pierre Després; Penny Gordon-Larsen; Carl J Lavie; Scott A Lear; Chiadi E Ndumele; Ian J Neeland; Prashanthan Sanders; Marie-Pierre St-Onge
Journal:  Circulation       Date:  2021-04-22       Impact factor: 29.690

8.  Quotient of Waist Circumference and Body Mass Index: A Valuable Indicator for the High-Risk Phenotype of Obesity.

Authors:  Xiao-Cong Liu; Yu Huang; Kenneth Lo; Yu-Qing Huang; Ji-Yan Chen; Ying-Qing Feng
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-31       Impact factor: 5.555

9.  Regional adiposity, cardiorespiratory fitness, and left ventricular strain: an analysis from the Dallas Heart Study.

Authors:  Nitin Kondamudi; Neela Thangada; Kershaw V Patel; Colby Ayers; Alvin Chandra; Jarret D Berry; Ian J Neeland; Ambarish Pandey
Journal:  J Cardiovasc Magn Reson       Date:  2021-06-14       Impact factor: 5.364

10.  Waist to height ratio is associated with an increased risk of mortality in Chinese patients with heart failure with preserved ejection fraction.

Authors:  Jianqiao Chen; Man Li; Benchuan Hao; Yulun Cai; Huiying Li; Wenli Zhou; Yujian Song; Shiqi Wang; Hongbin Liu
Journal:  BMC Cardiovasc Disord       Date:  2021-05-28       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.